Skip to content
Snoretox
  • Home
  • News
  • Bio Digital International Convention 2020
  • Investors
  • Human Trial Volunteers
  • Bulldog Trial Volunteers
  • Contact
  • Media

First Scientific Publication: Molecular Immunology. Volume 127. November 2020

October 2, 2020October 2, 2020 by Admin

Molecular Immunology. Volume 127. November 2020

Categories News
Post navigation
Snoretox Awarded “Barrier to Innovation” Waiver by the FDA CVM (USA Federal Drug Agency).

Scientific Publications: Molecular Immunology. November 2020

Molecular Immunology. Volume 127. November 2020

See more NEWS

Muscle tech: Sleep apnea therapeutic showcased at global biotech event

Ognomy Reviews Snoretox

What is Snoretox? Snoretox is a biotherapeutic that was invented and currently in development in the laboratories of RMIT University in Melbourne, Australia. The product, labelled Snoretox, is specifically designed to help deal with disorders stemming from hypotonia (low muscle tone)….more

© 2020 Snoretox • Powered by GeneratePress